NCT06661070

Brief Summary

The goal of this observational study is to investigate the efficacy of percutaneous electrolysis compared with dry needling on pain sensations and multifidus muscle properties in subjects with low back pain. The main questions it aims to answer are: The high-intensity and low-intensity percutaneous electrolysis may induce pressure pain threshold (PPT) changes in myofascial trigger points in the low back during the intervention compared with dry needling. Percutaneous electrolysis interventions may reduce stiffness in the multifidus muscle during the intervention compared with dry needling.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for not_applicable low-back-pain

Timeline
Completed

Started Nov 2024

Shorter than P25 for not_applicable low-back-pain

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 18, 2024

Completed
10 days until next milestone

First Posted

Study publicly available on registry

October 28, 2024

Completed
7 days until next milestone

Study Start

First participant enrolled

November 4, 2024

Completed
19 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 23, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 23, 2024

Completed
Last Updated

October 28, 2024

Status Verified

October 1, 2024

Enrollment Period

19 days

First QC Date

October 18, 2024

Last Update Submit

October 24, 2024

Conditions

Keywords

Low BackPainMultifidus muscleTrigger Pointsshear-wave elastographypain sensitivity

Outcome Measures

Primary Outcomes (1)

  • Pain changes in pain intensity before and after the intervention

    A 10-point Numerical Pain Rating Scale (NPRS; 0: no pain, 10: maximum pain) will be used to assess the patient's current level of shoulder pain, and the worst and lowest level of pain experienced in the preceding week in the shoulder area.

    Baseline, immediately after, and 24 after of intervention

Secondary Outcomes (2)

  • Pressure Pain Threshold

    Baseline, immediately after, and 24 after of intervention

  • Muscle stiffness

    Baseline, immediately after, and 24 after of intervention

Study Arms (3)

High-intensity percutaneous electrolysis (HIPE)

EXPERIMENTAL

The HIPE group receives a 660 mA galvanic current for 10 s.

Device: Electrolysis Percutaneous Therapeutic (EPTE)

Low-intensity percutaneous electrolysis (LIPE)

EXPERIMENTAL

The LIPE group receives a 220 mA × 30 s.

Device: Electrolysis Percutaneous Therapeutic (EPTE)

Dry Needling (DN)

ACTIVE COMPARATOR

The DN group received no galvanic current.

Other: Dry Needling

Interventions

EPTE device (Ionclinics, Valencia, Spain)

High-intensity percutaneous electrolysis (HIPE)Low-intensity percutaneous electrolysis (LIPE)

A dry needle with size 0.30 × 40 (Agupunt, Barcelona, Spain)

Dry Needling (DN)

Eligibility Criteria

Age35 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • to report low back pain of at least six months duration,
  • aged 35 to 50 years,
  • at least one active trigger point is present in the multifidus muscle.

You may not qualify if:

  • pharmacological (e.g., analgesics) or physiotherapy treatment before or during their participation in the study,
  • needle fear,
  • prior lower extremity or spine surgery, absence of pain, any musculoskeletal or neuropathic conditions (e.g., peripheral compressive neuropathy, radiculopathy, sarcopenia, fibromyalgia, muscle ruptures), traumatic injuries (e.g., fractures or fissures), or any medical condition or contraindication for needling treatment (e.g., anticoagulants).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Nursery, Physiotherapy and Podiatry

Madrid, 28040, Spain

Location

Related Publications (3)

  • Rozenfeld E, Finestone AS, Moran U, Damri E, Kalichman L. Test-retest reliability of myofascial trigger point detection in hip and thigh areas. J Bodyw Mov Ther. 2017 Oct;21(4):914-919. doi: 10.1016/j.jbmt.2017.03.023. Epub 2017 Mar 29.

  • Fernandez-de-Las-Penas C, Dommerholt J. International Consensus on Diagnostic Criteria and Clinical Considerations of Myofascial Trigger Points: A Delphi Study. Pain Med. 2018 Jan 1;19(1):142-150. doi: 10.1093/pm/pnx207.

  • Valera-Calero JA, Sanchez-Mayoral-Martin A, Varol U. Short-term effectiveness of high- and low-intensity percutaneous electrolysis in patients with patellofemoral pain syndrome: A pilot study. World J Orthop. 2021 Oct 18;12(10):781-790. doi: 10.5312/wjo.v12.i10.781. eCollection 2021 Oct 18.

MeSH Terms

Conditions

Low Back PainPain

Interventions

Dry Needling

Condition Hierarchy (Ancestors)

Back PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Complementary TherapiesTherapeuticsPhysical Therapy Modalities

Study Officials

  • Juan Antonio Valera-Calero, PhD

    Universidad Complutense de Madrid

    STUDY DIRECTOR

Central Study Contacts

Sebastian Klich, PhD, DSc

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: A triple-blinded, pilot randomized controlled trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

October 18, 2024

First Posted

October 28, 2024

Study Start

November 4, 2024

Primary Completion

November 23, 2024

Study Completion

November 23, 2024

Last Updated

October 28, 2024

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will not share

Locations